Optofluidics today announced that it's changing its corporate name to Halo Labs. The move comes after the company changed focus to making analytical tools for biopharmaceutical quality control. “We are excited about this new market, our new brand and our new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson have steered the company in this new direction after identifying significant limitations in current subvisible particle analysis tools.
The innovative new technology developed at Halo Labs solves key problems in the growing biopharmaceutical market. Halo Labs was awarded federal grants from the National Institute of Standards and Technology as well as the Food and Drug Administration to develop this technology and will be completing a fundraising round in the next few months to support their commercial expansion. Halo Labs is scheduled to unveil their flagship product at PEGS in May 1st of 2017.
About Halo Labs: Halo Labs is a scientific equipment manufacturer commercializing biopharmaceutical analysis instrumentation. The company was named Philadelphia Life Science Startup of 2012 by the Philadelphia Chamber of Commerce, is funded by the FDA, NIST and is venture backed by BioAdvance.